This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Matthias Scherf: Innovator in Prostate Cancer Research
Introduction
Matthias Scherf is a notable inventor based in Gröbenzell, Germany. He has made significant contributions to the field of cancer research, particularly in understanding the genetic factors associated with prostate cancer. His work has implications for diagnosis and treatment strategies in oncology.
Latest Patents
Matthias Scherf holds a patent titled "Genomic rearrangements associated with prostate cancer and methods of using the same." This patent reveals genomic arrangements in the chromosome 3q13 region that are linked to prostate cancer. It includes important findings such as rearrangements between the ZBTB20 and LSAMP genes, which can serve as biomarkers for prostate cancer. The patent also discusses the potential for stratifying prostate cancer based on ethnicity and severity, as well as identifying patients for targeted treatment. Additionally, it highlights the prevalence of PTEN gene deletions in prostate cancer among Caucasian subjects. The patent provides kits for diagnosing and prognosing prostate cancer.
Career Highlights
Throughout his career, Matthias Scherf has worked with esteemed organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and Genomatix Software GmbH. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Matthias has collaborated with notable colleagues such as Shiv Srivastava and Albert Dobi. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Matthias Scherf's innovative research in genomic rearrangements related to prostate cancer exemplifies the critical role of inventors in advancing medical science. His contributions not only enhance our understanding of cancer but also pave the way for improved diagnostic and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile